Enhanced Tubular Epithelial CD44 Expression in MRL-lpr Lupus Nephritis
Overview
Authors
Affiliations
The cell surface glycoprotein CD44 is expressed by cells of hematopoietic origin and constitutes a receptor for hyaluronic acid and matrix proteins. Because CD44 could play a role in recruiting inflammatory cells to sites of immune injury, we examined the renal CD44 expression in normal and in autoimmune MRL-lpr mice by immunohistochemistry and at a molecular level. In normal kidneys, immunoperoxidase staining for CD44 is restricted to interstitial cells and certain urothelial cells. In nephritic MRL-lpr, CD44 expression is prominent in perivascular inflammatory infiltrates and in glomerular crescents. Interestingly, CD44 is also focally expressed by cortical tubular epithelial cells (TEC) in nephritic MRL-lpr kidneys but not in normal kidneys. Reverse transcription-polymerase chain reaction (RT-PCR) as well as Northern blotting demonstrate that CD44 kidney mRNA levels are increased in nephritic MRL-lpr mice compared with normal mice. To further characterize the tubular CD44 expression, we examined cultured TEC (primary cultures and SV40-transformed TEC lines C1 and MCT). TEC constitutively express abundant cell surface CD44 that is modestly up-regulated in response to 18 hours stimulation with TNF-alpha (100 ng/ml), IFN-gamma (100 U/ml) and IL-1 (100 ng/ml). Northern analysis of TEC mRNA reveals a constitutive CD44 mRNA transcript at 3 kb. Stimulation with IFN-gamma or TNF-alpha for six hours markedly up-regulates CD44 mRNA expression in these cells. We conclude that mononuclear infiltration with CD44 positive cells and cytokine-induced up-regulation of CD44 by renal TEC is a prominent feature of MRL-lpr lupus nephritis. The contribution of CD44 induction on TEC to the pathogenesis of the autoimmune nephritic process in MRL-lpr remains to be determined.
Wong C, Gao L, Xu Y, Chau M, Zhang D, Yap D Front Immunol. 2024; 15:1443153.
PMID: 39411720 PMC: 11473352. DOI: 10.3389/fimmu.2024.1443153.
Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice.
Mockel T, Boegel S, Schwarting A PLoS One. 2023; 18(9):e0291619.
PMID: 37751458 PMC: 10522044. DOI: 10.1371/journal.pone.0291619.
Double negative T cells, a potential biomarker for systemic lupus erythematosus.
Alexander J, Jacob A, Chang A, Quigg R, Jarvis J Precis Clin Med. 2020; 3(1):34-43.
PMID: 32257532 PMC: 7093895. DOI: 10.1093/pcmedi/pbaa001.
T cells and autoimmune kidney disease.
Suarez-Fueyo A, Bradley S, Klatzmann D, Tsokos G Nat Rev Nephrol. 2017; 13(6):329-343.
PMID: 28287110 DOI: 10.1038/nrneph.2017.34.
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery.
Misra S, Hascall V, Atanelishvili I, Moreno Rodriguez R, Markwald R, Ghatak S Int J Cell Biol. 2015; 2015:537560.
PMID: 26448753 PMC: 4581573. DOI: 10.1155/2015/537560.